This inventor holds 1 USPTO granted patent. Top assignee: Lipopeptide Ab. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Gunter Weber - Innovator in Cancer Research
Introduction
Gunter Weber, based in Solna, Sweden, is a notable inventor renowned for his groundbreaking contributions to cancer research. With a focus on innovative solutions that inhibit cancer cell proliferation, he has made significant strides in therapeutic developments that could change the future of cancer treatment.
Latest Patents
Gunter Weber holds a crucial patent titled "Agents and use thereof." This invention provides agents for inhibiting the proliferation of cancer cells by targeting the biological activity of hCAP18/LL-37. The patent describes an innovative approach where the agent selectively alters the transcription, translation, or binding properties of hCAP18/LL-37. Specifically, the agents can comprise short interfering RNA (siRNA) molecules, antisense oligonucleotides, and compounds that exhibit a binding affinity for hCAP18/LL-37. Furthermore, the patent encompasses methodologies for inhibiting cancer cell proliferation in patients as well as kits designed for cancer diagnosis.
Career Highlights
Gunter Weber has been an influential researcher and inventor at Lipopeptide AB, where he employs his expertise to develop novel therapeutic agents against cancer. His commitment to innovation in the medical field is evident in his singular patent, which has potential implications for both treatment and diagnostic practices in oncology.
Collaborations
Throughout his career, Gunter has collaborated with skilled professionals such as Mona Ståhle and Johan Heilborn. Working alongside these talented individuals, Gunter has fostered an environment of innovation and discovery, leading to advances in cancer treatment methodologies.
Conclusion
Gunter Weber's innovative work exemplifies the power of creativity and collaboration in the field of cancer research. Through his patent on agents that inhibit cancer cell proliferation, he is contributing significantly to the fight against cancer. His ongoing endeavors at Lipopeptide AB, along with his professional partnerships, highlight the importance of research and development in transforming medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile